Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis. Novakova L, Axelsson M, Khademi M, Zetterberg H, Blennow K, Malmeström C, Piehl F, Olsson T, Lycke J J Neurochem. 2017 Apr; 141(2):296-304. PMID: 27787906. Abstract CommentRecommendBookmarkWatch
